Coverage
-
November 23, 2021
The attorneys who secured a $130 million settlement for Allergan investors who sued the pharmaceutical company over allegations that it participated in a generic drug price-fixing scheme will walk away with nearly $31 million for their trouble, according to a new court filing.
3 other articles on this case.
View all »